Literature DB >> 3534567

Hypoglycemia in hospitalized patients. Causes and outcomes.

K F Fischer, J A Lees, J H Newman.   

Abstract

We analyzed 137 episodes of hypoglycemia (serum glucose less than or equal to 49 mg per deciliter) occurring in 94 adult patients hospitalized during a six-month period at a tertiary care hospital. Forty-five percent of the patients had diabetes mellitus, and administered insulin was implicated in 90 percent of episodes in diabetics. Hypoglycemia in diabetic patients occurred under a variety of circumstances, frequently because of decreased caloric intake related to illness or hospital routine. Insulin-induced hypoglycemia also occurred during treatment of hyperkalemia (eight patients) or during hyperglycemia related to total parenteral nutrition (six patients). Forty-six of the 94 patients had chronic renal insufficiency, and 20 of these 46 had underlying diabetes mellitus. Thus, renal insufficiency unrelated to diabetes mellitus was the second most frequent diagnosis associated with hypoglycemia. The majority of other cases of hypoglycemia were related to liver disease, infections, shock, pregnancy, neoplasia, or burns. Hypoglycemia was not the apparent cause of death in any patient, but the overall hospital mortality was 27 percent and was related to the degree of hypoglycemia and the number of risk factors for hypoglycemia. We conclude that hypoglycemia is a common problem in hospitalized patients, is common in renal insufficiency, is usually iatrogenic, and correlates with high mortality in severely ill patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534567     DOI: 10.1056/NEJM198611133152002

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  57 in total

1.  Evaluation of patients admitted with hypoglycaemia to a teaching hospital in Central Anatolia.

Authors:  M Güven; F Bayram; K Güven; F Kelestimur
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

2.  Hypoglycaemia and heart failure.

Authors:  M Drah; R R Ghose
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

3.  Aldose reductase inhibition prevents lipopolysaccharide-induced glucose uptake and glucose transporter 3 expression in RAW264.7 macrophages.

Authors:  Aramati B M Reddy; Satish K Srivastava; Kota V Ramana
Journal:  Int J Biochem Cell Biol       Date:  2010-03-27       Impact factor: 5.085

4.  The metrics of glycaemic control in critical care.

Authors:  Iain M J Mackenzie; Tony Whitehouse; Peter G Nightingale
Journal:  Intensive Care Med       Date:  2011-01-06       Impact factor: 17.440

5.  A risk assessment based approach to the management of acute poisoning.

Authors:  F F S Daly; M Little; L Murray
Journal:  Emerg Med J       Date:  2006-05       Impact factor: 2.740

6.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

7.  Inducible nitric oxide synthase deficiency ameliorates skeletal muscle insulin resistance but does not alter unexpected lower blood glucose levels after burn injury in C57BL/6 mice.

Authors:  Michiko Sugita; Hiroki Sugita; Minhye Kim; Ji Mao; Yoshikazu Yasuda; Mayu Habiro; Shohei Shinozaki; Shingo Yasuhara; Nobuyuki Shimizu; J A Jeevendra Martyn; Masao Kaneki
Journal:  Metabolism       Date:  2011-08-03       Impact factor: 8.694

8.  Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities.

Authors:  Laura Boucai; William N Southern; Joel Zonszein
Journal:  Am J Med       Date:  2011-11       Impact factor: 4.965

9.  Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes.

Authors:  Farnoosh Farrokhi; Olena Klindukhova; Prakash Chandra; Limin Peng; Dawn Smiley; Christopher Newton; Francisco Pasquel; Maria E Fereira; Guillermo Umpierrez
Journal:  J Diabetes Sci Technol       Date:  2012-09-01

10.  Insulin regulation of renal glucose metabolism in conscious dogs.

Authors:  E Cersosimo; R L Judd; J M Miles
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.